PharVision Advisers’s Texas Roadhouse TXRH Stock Holding History

PharVision Advisers’s Portfolio TXRH Stock Details TXRH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,436	Closed	-$259K	–	516
2024 Q4	$259K	Buy	+1,436	New	+$270K	0.22%	203

Other funds holding TXRH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's TXRH Position: Q1 2025 in Review

PharVision Advisers sold out of Texas Roadhouse (TXRH) in Q1 2025, closing a stake of 1,436 shares — an estimated $259K sold.

PharVision Advisers first reported a position in TXRH in Q4 2024 and held it in 1 quarter. The position peaked at $259K in Q4 2024. 609 funds tracked by Wall St. Rank hold TXRH as of Q1 2025.

PharVision Advisers reported no remaining Texas Roadhouse position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 1,436 Texas Roadhouse shares in Q1 2025, an estimated $259K.
PharVision Advisers first reported a position in Texas Roadhouse in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Texas Roadhouse position peaked at $259K in Q4 2024.
609 funds tracked by Wall St. Rank held Texas Roadhouse as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.